Semaglutide (brand names Ozempic, Wegovy) is a GLP-1 receptor agonist that produces average weight loss of 12 to 17% of body weight
ER/MBOAT1 and AR/MBOAT2 signaling pathways Recently, membrane-bound O-acyltransferase domain-containing 2 (MBOAT2) was identified as a ferroptosis-suppressing gene through whole-genome CRISPR activation screening (Fig
Antioxidant Support : Glutathione and vitamin C can help defend cells against daily stressors
The global L-carnitine market is set for significant expansion, projected to grow from USD 257.61 Million in 2025 to USD 334.32 Million by 2031, exhibiting a compound annual growth rate of 4.44%
Acute effects of glucagon-like peptide-1, GLP-1(9-36 amide), and exenatide on mesenteric blood flow, cardiovascular parameters, and biomarkers in healthy volunteers
Sermorelin Therapy: Sermorelin is a synthetic peptide that mimics the bodys natural growth hormone-releasing hormone (GHRH)